Craif Inc., an AI-driven biotech company focused on early cancer detection, today unveiled a refreshed brand identity. With its technology now deployed across more than 2,400 medical institutions and 5,000+ drugstore locations in Japan, Craif is accelerating its international expansion in pursuit of its mission to help people around the world live longer, healthier lives.
Background
Following its founding in 2018, Craif spent approximately four years focused on research and development before developing its AI-driven urinary microRNA technology for early cancer detection. The company has since achieved steady commercial adoption in Japan, with adoption across more than 2,400 medical institutions, over 5,000 drugstore locations, and publicly funded programs through local governments.
Craif is now accelerating its global expansion, including the establishment of a wholly owned laboratory in San Diego, the relocation of its CEO to the United States, and the local hiring of a CFO. As Craif enters this significant new phase of global expansion, its logo has evolved to reflect that mission.
Building a brand identity that earns trust on the global stage is now central to Craif's next chapter.
As the company evolves from its early research and development stage toward transforming healthcare globally, the renewed logo reflects Craif's commitment to expanding its presence and impact worldwide.
About the New Brand Identity
Logotype: The redesigned Craif logotype is a fully custom design built to meet international brand standards. As Japanese companies expand internationally, even subtle inconsistencies in typography can influence brand perception and trust. With its global expansion in mind, Craif pursued a refined visual identity aligned with international standards and designed to be confidently represented by its U.S. team.
Symbol Mark: The company name Craif combines "Crane" (a symbol of longevity) and "Life." Expanding globally from Japan, one of the world's most advanced aging societies, Craif chose this name to embody its mission of helping people live longer, healthier lives. While retaining the folded crane motif and the vision it represents, the symbol mark has been refined into a more sophisticated design that conveys the image of the crane more intuitively.
Gradient: The new corporate logo features a gradient representing connection and continuity, bridging people and health, technology and aspiration, and today's science with tomorrow's medicine.
About Craif
Craif, founded in 2018, is an AI-driven biotechnology company focused on early cancer detection and precision medicine. By integrating advanced AI with its proprietary biomarker analysis platform, NANO IP® (NANO Intelligence Platform), Craif analyzes a wide range of biological signals, including DNA and microRNAs, from urine and other biofluids. This technology enables the development of highly advanced diagnostic tests that support earlier cancer detection, optimized treatment, and improved patient outcomes. Through the broader application of biotechnology and AI across healthcare and society, Craif is committed to advancing its vision of helping people live longer, healthier lives.
